156 related articles for article (PubMed ID: 18041028)
1. Novel anti-dengue monoclonal antibody recognizing conformational structure of the prM-E heterodimeric complex of dengue virus.
Puttikhunt C; Keelapang P; Khemnu N; Sittisombut N; Kasinrerk W; Malasit P
J Med Virol; 2008 Jan; 80(1):125-33. PubMed ID: 18041028
[TBL] [Abstract][Full Text] [Related]
2. [Secreted expression of dengue virus type I envelope glycoprotein in 293T cells].
Miao F; Li C; Zhang S; Wang XF; Li JD; Zhang QF; Liu QZ; Wei Y; Hang XT; Liang MF; Li DX
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Dec; 23(6):415-7. PubMed ID: 20718342
[TBL] [Abstract][Full Text] [Related]
3. A DNA vaccine candidate expressing dengue-3 virus prM and E proteins elicits neutralizing antibodies and protects mice against lethal challenge.
De Paula SO; Lima DM; de Oliveira França RF; Gomes-Ruiz AC; da Fonseca BA
Arch Virol; 2008; 153(12):2215-23. PubMed ID: 19002647
[TBL] [Abstract][Full Text] [Related]
4. Secretion of noninfectious dengue virus-like particles and identification of amino acids in the stem region involved in intracellular retention of envelope protein.
Purdy DE; Chang GJ
Virology; 2005 Mar; 333(2):239-50. PubMed ID: 15721358
[TBL] [Abstract][Full Text] [Related]
5. Identification of an epitope on the dengue virus membrane (M) protein defined by cross-protective monoclonal antibodies: design of an improved epitope sequence based on common determinants present in both envelope (E and M) proteins.
Falconar AK
Arch Virol; 1999; 144(12):2313-30. PubMed ID: 10664386
[TBL] [Abstract][Full Text] [Related]
6. [Recombinant envelope glycoprotein domain III of dengue virus inhibit virus infection].
Lu P; Wei Y; Cao SC; Li JD; Liu QZ; Zhang QF; Li C; Miao F; Zhang S; Hang XT; Liang MF; Li DX
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Jun; 22(3):177-9. PubMed ID: 19031695
[TBL] [Abstract][Full Text] [Related]
7. A strong endoplasmic reticulum retention signal in the stem-anchor region of envelope glycoprotein of dengue virus type 2 affects the production of virus-like particles.
Hsieh SC; Liu IJ; King CC; Chang GJ; Wang WK
Virology; 2008 May; 374(2):338-50. PubMed ID: 18252258
[TBL] [Abstract][Full Text] [Related]
8. Tetravalent neutralizing antibody response against four dengue serotypes by a single chimeric dengue envelope antigen.
Apt D; Raviprakash K; Brinkman A; Semyonov A; Yang S; Skinner C; Diehl L; Lyons R; Porter K; Punnonen J
Vaccine; 2006 Jan; 24(3):335-44. PubMed ID: 16125280
[TBL] [Abstract][Full Text] [Related]
9. The flavivirus precursor membrane-envelope protein complex: structure and maturation.
Li L; Lok SM; Yu IM; Zhang Y; Kuhn RJ; Chen J; Rossmann MG
Science; 2008 Mar; 319(5871):1830-4. PubMed ID: 18369147
[TBL] [Abstract][Full Text] [Related]
10. Production and characterization of anti-dengue capsid antibodies suggesting the N terminus region covering the first 20 amino acids of dengue virus capsid protein is predominantly immunogenic in mice.
Puttikhunt C; Ong-Ajchaowlerd P; Prommool T; Sangiambut S; Netsawang J; Limjindaporn T; Malasit P; Kasinrerk W
Arch Virol; 2009; 154(8):1211-21. PubMed ID: 19565324
[TBL] [Abstract][Full Text] [Related]
11. Antigenic cell associated dengue 2 virus proteins detected in vitro using dengue fever patients sera.
Abubakar S; Azila A; Suzana M; Chang LY
Malays J Pathol; 2002 Jun; 24(1):29-36. PubMed ID: 16329553
[TBL] [Abstract][Full Text] [Related]
12. [Immunochemical properties of West Nile virus protein prM and protein M C-end].
Bogachek MV; Protopopova EV; Ternovoĭ VA; Kachko AV; Ivanova AV; Ivanisenko VA; Shvalov AN; Loktev VB
Mol Biol (Mosk); 2007; 41(1):8-17. PubMed ID: 17380886
[TBL] [Abstract][Full Text] [Related]
13. C-terminal helical domains of dengue virus type 4 E protein affect the expression/stability of prM protein and conformation of prM and E proteins.
Tsai WY; Hsieh SC; Lai CY; Lin HE; Nerurkar VR; Wang WK
PLoS One; 2012; 7(12):e52600. PubMed ID: 23300717
[TBL] [Abstract][Full Text] [Related]
14. Enhancing biosynthesis and secretion of premembrane and envelope proteins by the chimeric plasmid of dengue virus type 2 and Japanese encephalitis virus.
Chang GJ; Hunt AR; Holmes DA; Springfield T; Chiueh TS; Roehrig JT; Gubler DJ
Virology; 2003 Feb; 306(1):170-80. PubMed ID: 12620809
[TBL] [Abstract][Full Text] [Related]
15. Novel binding between pre-membrane protein and claudin-1 is required for efficient dengue virus entry.
Gao F; Duan X; Lu X; Liu Y; Zheng L; Ding Z; Li J
Biochem Biophys Res Commun; 2010 Jan; 391(1):952-7. PubMed ID: 19962368
[TBL] [Abstract][Full Text] [Related]
16. Structural changes and functional control of the tick-borne encephalitis virus glycoprotein E by the heterodimeric association with protein prM.
Heinz FX; Stiasny K; Püschner-Auer G; Holzmann H; Allison SL; Mandl CW; Kunz C
Virology; 1994 Jan; 198(1):109-17. PubMed ID: 8259646
[TBL] [Abstract][Full Text] [Related]
17. Histidine at residue 99 and the transmembrane region of the precursor membrane prM protein are important for the prM-E heterodimeric complex formation of Japanese encephalitis virus.
Lin YJ; Wu SC
J Virol; 2005 Jul; 79(13):8535-44. PubMed ID: 15956595
[TBL] [Abstract][Full Text] [Related]
18. Antibody responses of dengue fever patients to dengue 2 (New Guinea C strain) viral proteins.
AbuBakar S; Azmi A; Mohamed-Saad N; Shafee N; Chee HY
Malays J Pathol; 1997 Jun; 19(1):41-51. PubMed ID: 10879241
[TBL] [Abstract][Full Text] [Related]
19. High-level expression of recombinant dengue virus type 2 envelope domain III protein and induction of neutralizing antibodies in BALB/C mice.
Zhang ZS; Yan YS; Weng YW; Huang HL; Li SQ; He S; Zhang JM
J Virol Methods; 2007 Aug; 143(2):125-31. PubMed ID: 17532481
[TBL] [Abstract][Full Text] [Related]
20. Dengue virus type 2 envelope protein displayed as recombinant phage attachment protein reveals potential cell binding sites.
Abd-Jamil J; Cheah CY; AbuBakar S
Protein Eng Des Sel; 2008 Oct; 21(10):605-11. PubMed ID: 18669522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
